Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of RPH-104 at different doses in patients with acute gout attack; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm | Conditions: Gout Attack | Phase 2 | Status: TERMINATED | Results posted: 2022-07-25